CompanyDrug

Manufacturing Challenges for Novo Nordisk’s Ozempic Impact Diabetes and Obesity Treatments in Europe

CompanyDrug

Skyline Therapeutics’ Gene Therapy Receives FDA Orphan Drug Designation for Retinitis Pigmentosa Treatment

CompanyDeals

CGeneTech Secures RMB 100 Million in Series C Financing to Advance Drug Commercialization and Clinical Pipeline

CompanyDrug

Innovent Biologics’ IBI363 Earns FDA Fast-Track Designation for Advanced Melanoma Treatment

CompanyMedical Device

Jafron Biomedical’s Blood Purification Devices Gain EU Market Approval Under MDR

Policy / Regulatory

China’s 13 Ministries Unite to Chart a Healthier Future for Rural Communities

CompanyDrug

Humanwell Healthcare’s Innovative Drug for Solid Tumors Gets Green Light from NMPA

CompanyDrug

Jiangsu Hengrui and Chongqing Genrix Launch Anti-IL-17 Therapies for Psoriasis in China

Policy / Regulatory

China Unveils Blueprint for Service Trade Expansion through Strategic Opening Up

Policy / Regulatory

China’s NHC Charts Ambitious Healthcare Reform Path with Emphasis on TCM and Technology

CompanyDeals

EpimAb’s EMB-06 Secures $635 Million Licensing Agreement with Vignette for Multiple Myeloma Therapy

CompanyDrug

Sanofi’s Tolebrutinib Shows Mixed Results in Phase III Multiple Sclerosis Trials